Hovione and Presspart extend technology partnership
Manufacturing Chemist, 3 May 2023
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Manufacturing Chemist, 3 May 2023
Silicon Republic, October 2, 2020
Safety First, Quality Always: We are continuously improving the safety of our operations with the patient’s safety in mind.
Hovione, the specialist integrated CDMO, just announced an expansion of its nasal drug delivery capabilities with the addition of a family of innovative nasal powder delivery devices developed in partnership with IDC.
Make your drug soluble with Dispersome® technology. Dispersome® is a solubility enhancement technology that relies on an innovative and naturally occurring excipient to develop amorphous solid dispersions with high drug loading and high bioavailability.
Commitment to partnership and joint innovation for cell and gene therapies
Hovione reported today recent capacity expansion and future plans in its sites in Portugal, Ireland and New Jersey.
Outsourced Pharma, April 2023